Cellular senescence: at the nexus between ageing and diabetes

Allyson K. Palmer, Birgit Gustafson, James L Kirkland, Ulf Smith

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Ageing and diabetes lead to similar organ dysfunction that is driven by parallel molecular mechanisms, one of which is cellular senescence. The abundance of senescent cells in various tissues increases with age, obesity and diabetes. Senescent cells have been directly implicated in the generation of insulin resistance. Recently, drugs that preferentially target senescent cells, known as senolytics, have been described and recently entered clinical trials. In this review, we explore the biological links between ageing and diabetes, specifically focusing on cellular senescence. We summarise the current data on cellular senescence in key target tissues associated with the development and clinical phenotypes of type 2 diabetes and discuss the therapeutic potential of targeting cellular senescence in diabetes.

Original languageEnglish (US)
JournalDiabetologia
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Cell Aging
Type 2 Diabetes Mellitus
Insulin Resistance
Obesity
Clinical Trials
Phenotype
Nexus
Pharmaceutical Preparations
Therapeutics

Keywords

  • Ageing
  • Cellular senescence
  • Dasatinib
  • Diabetes
  • Geroscience
  • Life course development
  • Quercetin
  • Review
  • Senolytics
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Cellular senescence : at the nexus between ageing and diabetes. / Palmer, Allyson K.; Gustafson, Birgit; Kirkland, James L; Smith, Ulf.

In: Diabetologia, 01.01.2019.

Research output: Contribution to journalReview article

Palmer, Allyson K. ; Gustafson, Birgit ; Kirkland, James L ; Smith, Ulf. / Cellular senescence : at the nexus between ageing and diabetes. In: Diabetologia. 2019.
@article{81161025ba824f96af59e8e8cabb5cd7,
title = "Cellular senescence: at the nexus between ageing and diabetes",
abstract = "Ageing and diabetes lead to similar organ dysfunction that is driven by parallel molecular mechanisms, one of which is cellular senescence. The abundance of senescent cells in various tissues increases with age, obesity and diabetes. Senescent cells have been directly implicated in the generation of insulin resistance. Recently, drugs that preferentially target senescent cells, known as senolytics, have been described and recently entered clinical trials. In this review, we explore the biological links between ageing and diabetes, specifically focusing on cellular senescence. We summarise the current data on cellular senescence in key target tissues associated with the development and clinical phenotypes of type 2 diabetes and discuss the therapeutic potential of targeting cellular senescence in diabetes.",
keywords = "Ageing, Cellular senescence, Dasatinib, Diabetes, Geroscience, Life course development, Quercetin, Review, Senolytics, Type 2 diabetes",
author = "Palmer, {Allyson K.} and Birgit Gustafson and Kirkland, {James L} and Ulf Smith",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s00125-019-4934-x",
language = "English (US)",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Cellular senescence

T2 - at the nexus between ageing and diabetes

AU - Palmer, Allyson K.

AU - Gustafson, Birgit

AU - Kirkland, James L

AU - Smith, Ulf

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Ageing and diabetes lead to similar organ dysfunction that is driven by parallel molecular mechanisms, one of which is cellular senescence. The abundance of senescent cells in various tissues increases with age, obesity and diabetes. Senescent cells have been directly implicated in the generation of insulin resistance. Recently, drugs that preferentially target senescent cells, known as senolytics, have been described and recently entered clinical trials. In this review, we explore the biological links between ageing and diabetes, specifically focusing on cellular senescence. We summarise the current data on cellular senescence in key target tissues associated with the development and clinical phenotypes of type 2 diabetes and discuss the therapeutic potential of targeting cellular senescence in diabetes.

AB - Ageing and diabetes lead to similar organ dysfunction that is driven by parallel molecular mechanisms, one of which is cellular senescence. The abundance of senescent cells in various tissues increases with age, obesity and diabetes. Senescent cells have been directly implicated in the generation of insulin resistance. Recently, drugs that preferentially target senescent cells, known as senolytics, have been described and recently entered clinical trials. In this review, we explore the biological links between ageing and diabetes, specifically focusing on cellular senescence. We summarise the current data on cellular senescence in key target tissues associated with the development and clinical phenotypes of type 2 diabetes and discuss the therapeutic potential of targeting cellular senescence in diabetes.

KW - Ageing

KW - Cellular senescence

KW - Dasatinib

KW - Diabetes

KW - Geroscience

KW - Life course development

KW - Quercetin

KW - Review

KW - Senolytics

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85071163041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071163041&partnerID=8YFLogxK

U2 - 10.1007/s00125-019-4934-x

DO - 10.1007/s00125-019-4934-x

M3 - Review article

C2 - 31451866

AN - SCOPUS:85071163041

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

ER -